Daisuke Aotani Selected Research

Daisuke Aotani Research Topics

8	Body Weight (Weight, Body) 01/2022 - 04/2012
7	Obesity 04/2022 - 04/2012
2	Insulin Resistance 01/2017 - 04/2012
2	Hyperphagia (Overeating) 01/2017 - 10/2016
2	Fatty Liver 09/2013 - 11/2012
2	Lipodystrophy 11/2012 - 10/2012
1	Sarcopenia 12/2023
1	Anorexia 04/2022
1	Weight Gain 01/2022
1	Congenital Abnormalities (Deformity) 03/2020
1	Hypophosphatasia 03/2020
1	Muscle Weakness 03/2020
1	Renal cysts and diabetes syndrome 09/2019
1	Cakut 09/2019
1	Infertility (Sterility) 01/2017
1	Morbid Obesity 01/2017
1	Hyperglycemia 10/2014
1	Type 2 Diabetes Mellitus (MODY) 10/2014
1	Overweight 10/2014
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 11/2012
1	Feeding and Eating Disorders (Eating Disorder) 10/2012
1	Edema (Dropsy) 04/2005

7	LeptinIBA 04/2022 - 04/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2012
3	Triglycerides (Triacylglycerol)IBA 10/2014 - 04/2012
2	LipidsIBA 04/2022 - 10/2014
2	Nicotine FDA Link 01/2022 - 01/2020
2	Exenatide (Byetta)FDA Link 01/2022 - 10/2014
2	Insulin (Novolin)FDA Link 11/2012 - 04/2012
2	AMP-Activated Protein KinasesIBA 11/2012 - 04/2012
1	LigandsIBA 12/2023
1	Sucrose (Saccharose)IBA 04/2022
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 03/2020
1	asfotase alfaIBA 03/2020
1	Alkaline PhosphataseIBA 03/2020
1	EndocannabinoidsIBA 01/2020
1	ElectrolytesIBA 09/2019
1	Hepatocyte Nuclear FactorsIBA 09/2019
1	des-n-octanoyl ghrelinIBA 01/2017
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2017
1	Mazindol (Mazanor)FDA Link 10/2016
1	Streptozocin (Streptozotocin)FDA Link 10/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2014
1	Therapeutic UsesIBA 11/2012
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2012
1	Islet Amyloid PolypeptideIBA 04/2012
1	Blood Glucose (Blood Sugar)IBA 04/2012
1	Hormones (Hormone)IBA 04/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2012
1	DiureticsIBA 04/2005
1	SodiumIBA 04/2005